Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Programmed death ligand 2 - A link between inflammation and bone loss in rheumatoid arthritis.

Stinne R Greisen | Tue W Kragstrup | Jesper Skovhus Thomsen | Aida Solhøj Hansen | Akilan Krishnamurthy | Kim Hørslev-Petersen | Merete Lund Hetland | Kristian Stengaard-Pedersen | Mikkel Østergaard | Lykke Midtbøll Ørnbjerg | Peter Junker | Arlene H Sharpe | Gordon J Freeman | Lakshmanan Annamalai | Malene Hvid | Søren K Moestrup | Ellen-Margrethe Hauge | Anca Irinel Catrina | Bent Deleuran
Journal of translational autoimmunity | 2020

Active rheumatoid arthritis (RA) is accompanied by increased appendicular and axial bone loss, closely associated to the degree of inflammation. The programmed death-1 (PD-1) pathway is important for maintaining peripheral tolerance, and its ligand PD-L2 has recently been associated with bone morphogenetic protein activity. Here, we report that PD-L2 plays a central role in RA osteoimmunology.

Pubmed ID: 32743513

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: P01 AI056299

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Sino Biological (tool)

RRID:SCR_003697

An Antibody supplier

View all literature mentions